z-logo
Premium
A new approach to toxin neutralization in S taphylococcus aureus therapy
Author(s) -
Parker Dane,
Prince Alice
Publication year - 2016
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.201642015
Subject(s) - staphylococcus aureus , leukocidin , panton–valentine leukocidin , columbia university , medicine , methicillin resistant staphylococcus aureus , biology , genetics , media studies , bacteria , sociology
Staphylococcus aureus is a significant human pathogen responsible for a range of diseases including pneumonia, sepsis, skin, and soft tissue infections. An important component of its success as a human pathogen is the production of a large array of virulence factors including several toxins. In this issue of EMBO Reports , Reyes‐Robles and colleagues [1][Reyes‐Robles T, 2016] identify a glycine‐rich motif shared by bicomponent leukocidins. When this motif is deleted, the altered toxin exerts dominant‐negative effects that neutralize leukocidin function and thus represents a potentially novel avenue for S. aureus therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom